- DOJ seeks immediate asset freeze, receivership against telehealth company Zealthy
- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Brain Cancer Awareness: The Importance of Molecular Testing for Patients with Rare Brain Tumors
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Progyny unveils new fertility benefit option for small, mid-size employers
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
Cui bono?
(Who benefits?) is not just for crime investigation! It's the #1 question to ask when the rules change for your healthcare or your license/workplace.
The Bureau of Professional Licensing (BPL) within the Department of Licensing and Regulatory Affairs (LARA) would like to inform you that the new Pharmacy Administrative Rules were effective as of February 29, 2024. A list of the notable changes is below. This is not intended to provide a comprehensive listing of all changes or current requirements. Licensees should review the rules and statute for a complete understanding of all applicable requirements.
The summary of changes is below:
For Pharmacy Services in Medical Institutions: Updates were made indicate that the limited number of medications may be stocked in patient care areas if pharmacist review and interpretation of the order before the administration of the first dose would adversely affect the patient’s medical condition.
For Pharmacist Licenses:
An individual participating in an unconventional internship is required to annually submit an affidavit from the internship supervisor including the type of activities performed and the number of hours completed.
A graduate from a program outside the United States may petition the board for approval of a maximum of 1,400 internship hours if the hours are not obtained through an approved educational program or under the personal charge of a Michigan-licensed pharmacist.
An internship preceptor is required to submit an affidavit including the number of internship hours completed by the intern in the practice of pharmacy, unless the hours are completed in an educational program.
The Multistate Pharmacy Jurisprudence Examination requirement is eliminated and replaced with an attestation that the applicant has sufficient knowledge of the Public Health Code and the Board of Pharmacy’s rules to competently practice pharmacy in Michigan.
For Pharmacy Licenses:If a pharmacist in charge (PIC) is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC and notify the department.
The 2023 revisions of USP Chapters 795 and 797 are adopted, with the exception of flavoring; inspection requirements are modified, including a 2-step inspection process for an in-state pharmacy that will compound sterile products and requiring out-of-state pharmacies that will not ship compounded sterile products into Michigan to submit inspections from their resident state boards of pharmacy or the National Association of Boards of Pharmacy (NABP) Verified Pharmacy Program.
Requirements for a pharmacy’s access to pharmacy laws and rules and reference texts are clarified.
A pharmacy that dispenses drugs is required to maintain a sink with running water, a refrigerator for the exclusive use of prescription drugs, and a telephone.
For Manufacturer Licenses:If a PIC or facility manager is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC or facility manager and notify the department.
Inspection and accreditation requirements were modified to provide the option of submitting an inspection from the United States Food and Drug Administration, the manufacturer’s resident state board of pharmacy, or NABP drug distributor accreditation.
For Wholesale Distributor and Wholesale Distributor-Broker Licenses:If a PIC or facility manager is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC or facility manager and notify the department.
For the Practice of Pharmacy:If a pharmacy intern completes final product verification under the supervision of a pharmacist, initials of both the pharmacy intern and the delegating pharmacist are required; modifies the locations where a pharmacy may operate an automated device; requires pharmacist review of orders and authorization of further dispensing within 48 hours when an automatic device is used as an after-hours cabinet, emergency kit, or when the system is accessed to treat the emergent needs of a patient;
The requirements for automated devices used in non-inpatient settings and in medical institutions were clarified.
A pharmacist may remotely access a pharmacy database as well as any other necessary databases that are routinely accessed to perform their functions and requires the pharmacist to provide adequate security.
The requirements for a pharmacist to dispense an emergency supply of insulin.
Please click HERE to view the revised Pharmacy rules.Our office is diligently working on updating relative information on our website to reflect the revisions of the revised rules. For more information, please visit our website at www.michigan.gov/bpl.
Please send questions about the revised rules to BPLHELP@michigan.gov.
More on the elimination of the Multistate Pharmacy Jurisprudence Examination requirement for pharmacist licenses:
Legal exam removed from pharmacist certification in Michigan
By Dustin Walsh - March 11, 2024It’s now easier to become a licensed pharmacist in the state of Michigan.
State regulators recently eliminated a widely used certification requirement by removing the Multistate Pharmacy Jurisprudence Exam, becoming only the second state in the U.S. to do so.
The jurisprudence exam is a 2.5-hour, 120-question multiple choice examination of federal and state laws formerly required in the state to become a certified pharmacist. Pharmacists are the only discipline in health care required to pass a law exam to receive licensure.
Experts are torn on whether removing the exam will jeopardize industry safety at a time when pharmacists are seeking more autonomy in the health care industry.
Keep up with all things West Michigan business. Sign up for our free newsletters today.
The elimination of the exam was quickly pushed through the Michigan Board of Pharmacy last summer in a controversial move and the new set of regulator rules was submitted to the Joint Committee on Administrative Rules in the legislature in July.
The committee finalized axing the exam on Feb. 29 and filed the rule change with the Secretary of State, making it official.
The elimination of the exam was supported by many in the industry, including national pharmacy chains and pharmacy benefits manager organizations.
During public comment last June, several individuals spoke in favor of getting rid of the exam. While none of the commenters disclosed their affiliations, at least one appeared to be a representative of a major insurer.
Jessica Morris, who according to her LinkedIn profile is a clinical consultant of strategic partnerships for Optum Inc., the pharmacy benefits subsidiary of UnitedHealth Group — the largest health insurer in the U.S. — called the exam “pointless” due to stopgap technology that ensures pharmacists follow all laws, state and federal.
But many pharmacists in the state disagreed with its removal, including the Michigan Pharmacists Association, who submitted complaints against the removal to the Joint Committee on Administrative Rules but were ultimately unsuccessful.
Eric Roath, director of government affairs for the industry group, questioned the wholesale removal of the exam from licensure in an interview with Crain’s last year.
“Pharmacists are far more likely to be brought before the pharmacy board for potential legal violations than any other provider,” Roath said. “Physician cases are usually due to a clinical error. Pharmacy is the highest-regulated field in health care. To say there are no better solutions to ensuring practice competency than to just remove the exam is wrong. The competency assessment is actually effective in verifying.”
Detractors say it’s likely chain pharmacies and multi-state health care providers favor eliminating the jurisprudence exams across the country in a bid to control their own costs and consolidate operations. Removing the exam could make it it easier for a consolidated pharmacy center in another state to fill scripts in Michigan, a move that could save millions of dollars.
Pharmacists are also one of the more prosecuted health care professions for violating laws.
A simple Google search of health insurance fraud by pharmacists in the region reveals more than a dozen indictments in the past five years that include distributing opioids to patients without a prescription to defrauding Medicare or Medicaid for reimbursement on drugs they didn’t prescribe or sold without a prescription.
In April last year, regulators in Idaho published a white paper in the American Journal of Pharmaceutical Education that stated there has been no evidence of public safety being jeopardized by its removal of the jurisprudence exam requirement. That article was co-written by Deeb Eid, who was listed as voluntary faculty at Ferris State University’s College of Pharmacy. His full-time job, though, is as a senior advisor of regulatory affairs for CVS.
It’ll likely take years to determine whether the removal of the MJPE impacts pharmacy operations or patient safety.
Great reporting!
Quite possibly the only deregulatory measure Michigan has taken, following Idaho or not.
Sure hope it doesn't offer the "bigs" an advantage over small start-ups. Finding out should be interesting.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














